Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJupiter Fund Management Regulatory News (JUP)

Share Price Information for Jupiter Fund Management (JUP)

Share Price is delayed by 15 minutes
Get Live Data
169.60    1.40 (0.83%)
Bid:
169.60
Ask:
170.00
Spread: 0.40 (0.236%)
Market Cap: £841.09m
JUP Live PriceLast checked at - London Stock Exchange

Intraday Jupiter Fund Management Share Chart

Director/PDMR Shareholding

12 Mar 2024 16:30

RNS Number : 5774G
Jupiter Fund Management PLC
12 March 2024

12 March 2024

JUPITER FUND MANAGEMENT PLC (the "Company")

Director Shareholding

On 8 March 2024, Matthew Beesley exercised options over 115,763 ordinary shares of 2 pence each in the Company ("Shares"), granted under the Company's 2018 Deferred Bonus Plan ("DBP"). Matthew Beesley subsequently sold 56,266 Shares at £0.902797 per Share, sufficient to cover tax liabilities and expenses arising on the exercise.

On 8 March 2024, Wayne Mepham exercised options over 109,901 Shares granted under the DBP. Wayne Mepham subsequently sold 53,420 Shares at £0.902572 per Share, sufficient to cover tax liabilities and expenses arising on the exercise.

The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

1.

Details of the person discharging managerial responsibilities/ person closely associated

a)

Name

Matthew Beesley

2.

Reasons for the notification

a)

Position / status

Chief Executive Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

a)

Name

Jupiter Fund Management plc

b)

Legal Identifier Code

5493003DJ1G01IMQ7S28

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary shares of 2 pence

GB00B53P2009

b)

Nature of the transaction

Exercise of options over 115,763 Shares granted under the DBP

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

115,763

d)

Aggregated information

- Aggregated volume

-Price

N/A (single transaction)

e)

Date of the transaction

8 March 2024

f)

Place of Transaction

Outside a trading venue

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary shares of 2 pence

GB00B53P2009

b)

Nature of the transaction

Sale of Shares sufficient to cover tax and expenses arising on the exercise of Share options described above in this disclosure.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.902797 per Share

56,266

d)

Aggregated information

- Aggregated volume

-Price

N/A (single transaction)

e)

Date of the transaction

8 March 2024

f)

Place of Transaction

London Stock Exchange, XLON

1.

Details of the person discharging managerial responsibilities/ person closely associated

a)

Name

Wayne Mepham

2.

Reasons for the notification

a)

Position / status

Chief Financial & Operating Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

a)

Name

Jupiter Fund Management plc

b)

Legal Identifier Code

5493003DJ1G01IMQ7S28

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary shares of 2 pence

GB00B53P2009

b)

Nature of the transaction

Exercise of options over 109,901 Shares granted under the DBP.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

109,901

d)

Aggregated information

- Aggregated volume

-Price

N/A (single transaction)

e)

Date of the transaction

8 March 2024

f)

Place of Transaction

Outside a trading venue

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary shares of 2 pence

GB00B53P2009

b)

Nature of the transaction

Sale of Shares sufficient to cover tax and expenses arising on the exercise of Share options described above in this disclosure.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.902572 per Share

53,420

d)

Aggregated information

- Aggregated volume

-Price

N/A (single transaction)

e)

Date of the transaction

8 March 2024

f)

Place of Transaction

London Stock Exchange, XLON

For further information please contact:

Investors

Media

Jupiter

Helen Archbold

+44 (0)20 3817 1609

Despina Constantinides

+44 (0)20 3817 1278

Edelman Smithfield

Latika Shah

+44 (0)7950 671 948

Andrew Wilde

+44 (0)7786 022 022

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHSFUFMEELSESD
Date   Source Headline
26th Mar 20255:15 pmRNSTransaction in Own Shares
25th Mar 20255:17 pmRNSTransaction in Own Shares
25th Mar 202512:30 pmRNSAnnual Report and Accounts and Notice of AGM
24th Mar 20255:30 pmRNSTransaction in Own Shares
21st Mar 20255:27 pmRNSTransaction in Own Shares
20th Mar 20255:19 pmRNSTransaction in Own Shares
19th Mar 20255:45 pmRNSTransaction in Own Shares
18th Mar 20255:17 pmRNSTransaction in Own Shares
17th Mar 20255:30 pmRNSTransaction in Own Shares
14th Mar 20256:00 pmRNSTransaction in Own Shares
14th Mar 202512:30 pmRNSRedemption of Subordinated Notes
13th Mar 20255:37 pmRNSTransaction in Own Shares
12th Mar 20255:55 pmRNSTransaction in Own Shares
11th Mar 20256:00 pmRNSTransaction in Own Shares
11th Mar 20254:00 pmRNSDirector Shareholding
10th Mar 20255:45 pmRNSTransaction in Own Shares
7th Mar 20255:30 pmRNSTransaction in Own Shares
6th Mar 20255:45 pmRNSTransaction in Own Shares
5th Mar 20255:30 pmRNSTransaction in Own Shares
5th Mar 20254:00 pmRNSDirector Shareholding
4th Mar 20256:25 pmRNSTransaction in Own Shares - Replacement
4th Mar 20255:35 pmRNSTransaction in Own Shares
3rd Mar 20255:35 pmRNSTransaction in Own Shares
3rd Mar 20254:30 pmRNSDirector Shareholding
3rd Mar 20252:10 pmRNSHolding(s) in Company
28th Feb 20257:30 amRNSNon-executive Director Changes
27th Feb 20257:00 amRNSAnnual Financial Report
27th Feb 20257:00 amRNSShare Buyback Programme
27th Feb 20257:00 amRNSIntention to Redeem Subordinated Notes
26th Feb 20255:00 pmRNSHolding(s) in Company
7th Feb 20251:36 pmRNSHolding(s) in Company
29th Jan 20258:19 amRNSHolding(s) in Company
21st Jan 20253:30 pmRNSHolding(s) in Company
17th Jan 20252:30 pmRNSHolding(s) in Company
10th Jan 202510:12 amRNSHolding(s) in Company
6th Jan 20253:00 pmRNSNon-executive Director Role Changes
20th Dec 20242:53 pmRNSHolding(s) in Company
18th Dec 20242:00 pmRNSDirector Shareholding
28th Oct 202411:51 amRNSHolding(s) in Company
25th Oct 20243:00 pmRNSHolding(s) in Company
25th Oct 202411:08 amRNSHolding(s) in Company
11th Oct 20247:00 amRNSTrading Update and Notice of Results
2nd Oct 20242:15 pmRNSHolding(s) in Company
30th Sep 202411:30 amRNSAppointment of a Non-Executive Director
27th Sep 202412:46 pmRNSHolding(s) in Company
13th Sep 202410:43 amRNSHolding(s) in Company
12th Sep 202412:00 pmRNSDirector/PDMR Shareholding
20th Aug 202410:24 amRNSHolding(s) in Company
19th Aug 20242:55 pmRNSHolding(s) in Company
12th Aug 20244:00 pmRNSNon-Executive Director - New External Role

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.